After hours:
Chart Events
Performance Outlook
| Previous Close | 0.5000 |
| Open | 0.5000 |
| Bid | 0.4851 x 800 |
| Ask | 0.5100 x 1000 |
| Day's Range | 0.4820 - 0.5096 |
| 52 Week Range | 0.3690 - 8.0750 |
| Volume | |
| Avg. Volume | 1,202,316 |
| Market Cap | 3.528M |
| Beta (5Y Monthly) | 1.07 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.6740 |
| Earnings Date | Mar 07, 2023 - Mar 13, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.50 |
- InvestorPlace
7 Top Short-Squeeze Candidates to Watch in February
While everyone knows that in order to have a market, there must be bulls and bears, that’s not going to stop people from attempting to garner intense profits from top short-squeeze candidates. To quickly summarize, shorting stocks involves borrowing shares to initiate the “negative” position. At some point, though, those borrowed shares must be returned. For the bears, they can be returned either at a profit or a loss. Now, in order to panic the bears into buying back their borrowed shares befor
- Business Wire
Myomo Appoints Yitzchak Jacobovitz to its Board of Directors
BOSTON, January 30, 2023--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Yitzchak Jacobovitz as a Class II director effective January 27, 2023, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has six directors.
- Business Wire
Myomo Announces Closing of $6.5 Million Upsized Public Offering
BOSTON, January 17, 2023--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the closing of its previously announced "best efforts" public offering of 20,000,000 shares of common stock (or common stock equivalents in lieu thereof) at a public offering price of $0.325 per share for aggregate gross proceeds of approximately $6.5
